Cargando…

Sox2 Is an Androgen Receptor-Repressed Gene That Promotes Castration-Resistant Prostate Cancer

Despite advances in detection and therapy, castration-resistant prostate cancer continues to be a major clinical problem. The aberrant activity of stem cell pathways, and their regulation by the Androgen Receptor (AR), has the potential to provide insight into novel mechanisms and pathways to preven...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kregel, Steven, Kiriluk, Kyle J., Rosen, Alex M., Cai, Yi, Reyes, Edwin E., Otto, Kristen B., Tom, Westin, Paner, Gladell P., Szmulewitz, Russell Z., Vander Griend, Donald J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543364/ https://www.ncbi.nlm.nih.gov/pubmed/23326489 http://dx.doi.org/10.1371/journal.pone.0053701

Ejemplares similares

Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer
por: Kregel, Steven, et al.
Publicado: (2016)

Sustained Complete Response to Cytotoxic Therapy and the PARP Inhibitor Veliparib in Metastatic Castration-Resistant Prostate Cancer – A Case Report
por: VanderWeele, David J., et al.
Publicado: (2015)

SOX2 Mediates Metabolic Reprogramming of Prostate Cancer Cells
por: de Wet, Larischa, et al.
Publicado: (2022)

Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer
por: Reyes, Edwin E, et al.
Publicado: (2014)

Transcriptional repression by androgen receptor: roles in castration-resistant prostate cancer
por: Gritsina, Galina, et al.
Publicado: (2019)

Circulating tumor cells capture disease evolution in advanced prostate cancer
por: Lack, Justin, et al.
Publicado: (2017)

Castration plus oestrogen treatment induces but castration alone suppresses epithelial cell apoptosis in an androgen-sensitive rat prostatic adenocarcinoma.
por: Westin, P., et al.
Publicado: (1995)

Regulation of Prostate Androgens by Megalin and 25-hydroxyvitamin D Status: Mechanism for High Prostate Androgens in African American Men
por: Garcia, Jason, et al.
Publicado: (2023)

Prostate cancer: a presentation of clinicopathologic prognosticators among Filipino and American men at radical prostatectomy
por: Grageda, Mayen T, et al.
Publicado: (2021)

Interplay Between SOX9, Wnt/β-Catenin and Androgen Receptor Signaling in Castration-Resistant Prostate Cancer
por: Khurana, Namrata, et al.
Publicado: (2019)

Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription
por: Jia, Lin, et al.
Publicado: (2018)

Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer
por: Saoud, Ragheed, et al.
Publicado: (2020)

Perineal dermoid cyst in a young male
por: Sloan, Matthew, et al.
Publicado: (2020)

Conversion of Androgen Receptor Signaling From a Growth Suppressor in Normal Prostate Epithelial Cells to an Oncogene in Prostate Cancer Cells Involves a Gain of Function in c-Myc Regulation
por: Vander Griend, Donald J., et al.
Publicado: (2014)

Loss of Androgen Receptor-Dependent Growth Suppression by Prostate Cancer Cells Can Occur Independently from Acquiring Oncogenic Addiction to Androgen Receptor Signaling
por: D'Antonio, Jason M., et al.
Publicado: (2010)

Reply to X. Farré et al
por: Vickers, Andrew, et al.
Publicado: (2023)

The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review
por: Vickman, Renee E., et al.
Publicado: (2020)

OR05-05 A Novel Model Of Prostate Cancer Suggests Enzalutamide Functions Through The Immune System To Diminish Castration Resistant And Metastatic Growth
por: Kregel, Steven
Publicado: (2023)

Transurethral resection and surveillance of a well-differentiated neuroendocrine tumor in a ileal neobladder
por: Kang, Audry, et al.
Publicado: (2020)

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
por: Chuu, Chih-Pin, et al.
Publicado: (2011)

Androgen receptor expression reduces stemness characteristics of prostate cancer cells (PC3) by repression of CD44 and SOX2
por: Srinivasan, Deepa, et al.
Publicado: (2018)

Interleukin-23 Represses the Level of Cell Senescence Induced by the Androgen Receptor Antagonists Enzalutamide and Darolutamide in Castration-Resistant Prostate Cancer Cells
por: Gupta, Siddharth, et al.
Publicado: (2020)

Effect of SOX2 Repression on Corneal Endothelial Cells
por: Hwang, Jin Sun, et al.
Publicado: (2020)

MTA3 Represses Cancer Stemness by Targeting the SOX2OT/SOX2 Axis
por: Du, Liang, et al.
Publicado: (2019)

Inhibiting androgen receptor nuclear entry in castration-resistant prostate cancer
por: Pollock, Julie A., et al.
Publicado: (2016)

Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer
por: Montgomery, Bruce, et al.
Publicado: (2010)

Nucleolin represses transcription of the androgen receptor gene through a G-quadruplex
por: Miranti, Cindy K., et al.
Publicado: (2020)

Androgen receptor pathway inhibitors, prostate cancer, and older adults: a global Young International Society of Geriatric Oncology drug review
por: Mir, Nabiel, et al.
Publicado: (2023)

Allele-specific repression of Sox2 through the long non-coding RNA Sox2ot
por: Messemaker, Tobias C., et al.
Publicado: (2018)

Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer
por: Stein, Mark N, et al.
Publicado: (2014)

Persistent androgen receptor addiction in castration-resistant prostate cancer
por: Schweizer, Michael T., et al.
Publicado: (2015)

The expression of AURKA is androgen regulated in castration-resistant prostate cancer
por: Kivinummi, Kati, et al.
Publicado: (2017)

Androgen Receptor Signaling in the Development of Castration-Resistant Prostate Cancer
por: Feng, Qin, et al.
Publicado: (2019)

Tzfp Represses the Androgen Receptor in Mouse Testis
por: Furu, Kari, et al.
Publicado: (2013)

Identification of Androgen Receptor Metabolic Correlome Reveals the Repression of Ceramide Kinase by Androgens
por: Camacho, Laura, et al.
Publicado: (2021)

Castration delays epigenetic aging and feminizes DNA methylation at androgen-regulated loci
por: Sugrue, Victoria J, et al.
Publicado: (2021)

Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study
por: Armstrong, Andrew J., et al.
Publicado: (2019)

Dominant-Negative Androgen Receptor Inhibition of Intracrine Androgen-Dependent Growth of Castration-Recurrent Prostate Cancer
por: Titus, Mark A., et al.
Publicado: (2012)

Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions
por: Decker, Keith F., et al.
Publicado: (2012)

Correction: Nucleolin represses transcription of the androgen receptor gene through a G-quadruplex
por: Miranti, Cindy K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gqa4s6o5mn9q68r2ha2oh5tb8c